Description

In type 2 diabetic with CV risk for effective control & favorable PPG

Combination:

Voglibose 0.2 mg /0.3mg + Glimepiride 2 mg + Metformin 500 mg Tablets

• Reduces the risk of cardiovascular events
• Prevents nocturnal hypoglycemia
• Lowers the daily glycemic excursions
• Improved PPG more favorably than LSM (Life Style Modification)
• Decreases carbohydrate absorption and decreases PPHG
• Mobilizes endogenous pool of insulinotropics
• Does not alter rate of gastric emptying
• Well tolerated useful in elderly patients and in those with hepatic impairment or mild to moderate renal function

Best choice for the DIABETIC People with heart failure